Blood glucose control with n-acylated glucosamines

Details Blood glucose control with n-acylated glucosamines Blood glucose control with n-acylated glucosamines

A - Human Necessities

61

K

A61K 31/7008 (2006.01)

Patent

CA 2491763

1. A method for a treatment selected from the group consisting of (a) reducing elevated blood glucose, (b) reducing complications of diseases that are associated with elevations of blood glucose, and (c) prevention of diseases that develop as a result of elevated blood glucose in a mammal, said method comprising administering to said mammal an effective amount of a N-acylated-2-glucosamine derivative of the general formula (I): (see formula I) wherein R is an alkyl radical of the general formula C n H2n+1 wherein n is selected from 2-12; and pharmaceutically-acceptable salts, esters and glucosides thereof.

Affiliated with

Also associated with

Rating

Blood glucose control with n-acylated glucosamines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Blood glucose control with n-acylated glucosamines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Blood glucose control with n-acylated glucosamines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1569548